Epclusa
-
Hepatitis C Update: FDA Approves Gilead's New Drug to Treat All Form of Hepatitis C
FDA approved new combination drug Epclusa developed by Gilead to treat all six major forms of hepatitis C with or without liver damage.
Latest Research Articles